Self-developed and patented innovations in m-health

Brighter

Brighter AB is a Swedish company that develops medical devices to treat diseases with a high unmet need. Its lead product in development is Actiste, for diabetes management.

Financials

Brighter

SEKm 2018 2019 2020
Sales 0 4 50
Sales growth (%) -100 N/A 1030,4
EBITDA -70 -72 N/A
EBITDA margin (%) -3609,3 N/A -1621,9
EBIT adj -50 -74 -83
EBIT adj margin (%) -3609,3 N/A -1873,3
Pretax profit -76 -84 -75
EPS rep -1,48 -1,76 -1,8
EPS growth (%) -11,5 -18,8 -2,3
EPS adj -1,48 -1,76 -1,8
DPS 0 0 0
EV/EBITDA (x) -7,8 -5,7 -7,8
EV/EBIT adj (x) -7,3 -5 -6,5
P/E (x) -5,9 -4,9 -4,8
P/E adj (x) -5,9 -4,9 -4,8
EV/sales (x) N/A 92,7 9,6
FCF yield (%) -15,9 -12,2 -12,4
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 0,3 2,1 1,3

Main shareholders

Brighter

Main shareholders Share capital % Voting shares % Verified
Avanza Pension 13.1 % 13.1 % 31 Dec 2018
Truls Sjöstedt 8.9 % 8.9 % 9 Jul 2018
Michael Göran Erik Frantzén 7.1 % 7.1 % 31 Mar 2017
Recall Capital Nordic AB 2.8 % 2.8 % 31 Dec 2018
Jonas Metzger 1.6 % 1.6 % 31 Dec 2018
Minh Nguyen 1.4 % 1.4 % 31 Dec 2018
Robert Mellin 1.3 % 1.3 % 31 Dec 2018
Swedbank Försäkring 1.2 % 1.2 % 31 Dec 2018
Nordnet Pensionsförsäkring 1.1 % 1.1 % 31 Dec 2018
Henrik Norström 0.9 % 0.9 % 11 Oct 2018
Source: Holdings by Modular Finance AB

Insider list

Brighter

Name
Henrik Norström
Henrik Norström
Henrik Norström
Henrik Norström
Henrik Norström
Truls Sjöstedt
Truls Sjöstedt
Henrik Norström
Henrik Norström
Jan Stålemark
Show More